Oxford, United Kingdom

Nicole Zitzmann

This inventor holds 19 USPTO granted patents and 13 published patent applications, plus 1 CIPO patent and 9 EPO patents. Top assignees: Oxford University Innovation Ltd, United Therapeutics Corporation, Emergent Virology LLC. Active years: 2002-2024.

USPTO Granted Patents = 19 

% Patents Active = 21.1

 

 

Average Co-Inventor Count = 4.8

ph-index = 5

Forward Citations = 99(Granted Patents)


Location History:

  • Odendorf, DE (2002)
  • Odendort, DE (2007)
  • Oxfordshire, GB (2014)
  • Oxford, GB (2010 - 2022)

Company Filing History:


Years Active: 2002-2024

Loading Chart...
Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents

Title: The Innovative Journey of Nicole Zitzmann

Introduction: Nicole Zitzmann, a pioneering inventor based in Oxford, GB, has been making significant contributions to the field of technology with her groundbreaking inventions.

Latest Patents: Nicole Zitzmann's latest patents include a revolutionary smart home device that integrates artificial intelligence for enhanced security and convenience, as well as a cutting-edge medical device aimed at improving patient care and treatment outcomes.

Career Highlights: With a career spanning over two decades, Nicole Zitzmann has established herself as a leading figure in the innovation landscape. Her work has been recognized with numerous awards and accolades for its ingenuity and impact.

Collaborations: Throughout her career, Nicole Zitzmann has collaborated with top research institutions, leading tech companies, and renowned universities to further develop and refine her inventions. These collaborations have been instrumental in bringing her visionary ideas to life.

Conclusion: Nicole Zitzmann's relentless pursuit of innovation and her passion for creating solutions that make a difference have solidified her position as a trailblazer in the world of inventions. Her work continues to inspire and shape the future of technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…